Myriad Genetics Inc Cash Flow-to-Debt Ratio
Myriad Genetics Inc cash flow-to-debt ratio. Myriad Genetics Inc (MYGN) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2026, meaning its operating cash flow of $-8.30 Million could theoretically repay 0% of its total liabilities ($335.00 Million) in one year. Check how high is Myriad Genetics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Myriad Genetics Inc (1995–2025)
Cash flow-to-debt ratio of Myriad Genetics Inc from 1995 to 2025. Historical debt coverage capacity for Myriad Genetics Inc across 30 annual periods. Check Myriad Genetics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Myriad Genetics Inc Cash Flow-to-Debt Ratio by Year (1995–2025)
Myriad Genetics Inc cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for Myriad Genetics Inc. For the full cash flow conversion analysis, see cash flow conversion of Myriad Genetics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $1.80 Million | $338.60 Million | ▲ +120.0% |
| 2024 | -0.03x | $-8.70 Million | $326.50 Million | ▲ +91.3% |
| 2023 | -0.31x | $-110.90 Million | $363.30 Million | ▲ +10.1% |
| 2022 | -0.34x | $-106.30 Million | $312.90 Million | ▼ -744.6% |
| 2021 | 0.05x | $18.60 Million | $352.90 Million | ▼ -66.1% |
| 2020 | 0.16x | $83.70 Million | $537.80 Million | ▼ -11.9% |
| 2019 | 0.18x | $83.70 Million | $473.80 Million | ▼ -68.1% |
| 2018 | 0.55x | $115.90 Million | $209.20 Million | ▲ +130.0% |
| 2017 | 0.24x | $106.20 Million | $440.90 Million | ▼ -80.8% |
| 2016 | 1.26x | $166.30 Million | $132.40 Million | ▼ -6.9% |
| 2015 | 1.35x | $140.50 Million | $104.10 Million | ▼ -25.6% |
| 2014 | 1.81x | $190.20 Million | $104.80 Million | ▼ -21.5% |
| 2013 | 2.31x | $173.90 Million | $75.23 Million | ▼ -10.4% |
| 2012 | 2.58x | $141.80 Million | $54.98 Million | ▼ -13.2% |
| 2011 | 2.97x | $130.83 Million | $44.03 Million | ▼ -30.5% |
| 2010 | 4.28x | $155.09 Million | $36.27 Million | ▲ +63.7% |
| 2009 | 2.61x | $84.04 Million | $32.17 Million | ▲ +85.6% |
| 2008 | 1.41x | $103.74 Million | $73.69 Million | ▲ +291.6% |
| 2007 | -0.73x | $-25.85 Million | $35.18 Million | ▲ +29.7% |
| 2006 | -1.04x | $-28.03 Million | $26.82 Million | ▼ -4.4% |
| 2005 | -1.00x | $-23.30 Million | $23.29 Million | ▲ +51.1% |
| 2004 | -2.05x | $-30.88 Million | $15.08 Million | ▲ +14.9% |
| 2003 | -2.41x | $-46.54 Million | $19.34 Million | ▼ -320.8% |
| 2002 | -0.57x | $-16.31 Million | $28.52 Million | ▼ -393.6% |
| 2001 | -0.12x | $-3.78 Million | $32.58 Million | ▼ -119.4% |
| 2000 | 0.60x | $17.16 Million | $28.67 Million | ▲ +122.9% |
| 1999 | -2.61x | $-14.10 Million | $5.40 Million | ▼ -269.3% |
| 1998 | -0.71x | $-7.00 Million | $9.90 Million | ▼ -6.1% |
| 1997 | -0.67x | $-6.60 Million | $9.90 Million | ▼ -547.6% |
| 1995 | 0.15x | $1.40 Million | $9.40 Million | — |